Cynvenio Neoadjuvant Breast Cancer Registry Study

Cynvenio Neoadjuvant Breast Cancer Registry Study

Cynvenio and Targeted Medical Education Research (TME) are conducting a multi-center registry study which will include at least 10 specialized breast practices and over 150 patients to be monitored over three years with Cynvenio’s ClearID Breast Cancer blood test. Registry data will be leveraged to understand the value of ClearID as a treatment assessment and monitoring tool and to refine test algorithms.

/*This is to open gallery links in new window*/